org placeholder image

Scott Mordecai

Principal Research Associate at CRISPR Therapeutics

  • LinkedIn

Email Email: s****@crisprtx.com

phone noPhone Number: (***)-***-****

map
CRISPR THERAPEUTICS

CRISPR THERAPEUTICS

  • description Description
    CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is...

    Read More

  • Employees count Employees 201-500
  • Revenue Revenue 100 Million to 250 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

CRISPR Therapeutics Org Chart and Mapping

Employees

Alexandra Moussouris

Executive Director, Data Management

Nicole McBrine

Sr. Specialist, Clinical Sample Management

Diana Gálvez

Quality Control Analyst, Analytical

Scott Mordecai

Principal Research Associate

Salonee Parikh

Sr. Clinical Trial Associate

Apoorva Muttagi

Principal Research Associate

Frequently Asked Questions Regarding Scott Mordecai

Answer: Scott Mordecai works for CRISPR Therapeutics as Principal Research Associate

Answer: Scott Mordecai’s role in CRISPR Therapeutics is Principal Research Associate

Answer: Scott Mordecai's email address is s***@gmail.com

Answer: Scott Mordecai's business email address is s****@crisprtx.com

Answer: Scott Mordecai’s direct phone number is (***)-***-****

Answer: Scott Mordecai works in the industry of: Biotechnology

Answer: Scott Mordecai works CRISPR Therapeutics located at 828 Winter St, Boston, Massachusetts, 02451, United States

Answer: CRISPR Therapeutics's Principal Research Associate is Scott Mordecai

Answer: Scott Mordecai contact details:

  • Phone number  :  (***)-***-****
  • Email  :  s****@crisprtx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access